Antilipemic Drugs
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
EZETIMIBE: products 1 to 20 of 20.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Ach-Ezetimibe 10mg TabDIN 02425610 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| Act Ezetimibe 10mg TabDIN 02414716 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| AG-Ezetimibe 10mg TabDIN 02475898 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| Apo-Ezetimibe 10mg TabDIN 02427826 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| Auro-Ezetimibe 10mg TabDIN 02469286 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| Bio-Ezetimibe 10mg TabDIN 02425211 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| Ezetimibe 10mg TabDIN 02429659 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| Ezetimibe 10mg TabDIN 02431300 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| Ezetrol 10mg TabDIN 02247521 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| GLN-Ezetimibe 10mg TabDIN 02460750 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| Jamp-Ezetimibe 10mg TabDIN 02423235 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| M-Ezetimibe 10mg TabDIN 02467437 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| Mar-Ezetimibe 10mg TabDIN 02422662 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| Mint-Ezetimibe 10mg TabDIN 02423243 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| NRA-Ezetimibe 10mg TabDIN 02481669 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| NRA-Ezetimibe Tablets 10mg TabDIN 02536420 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| PMS-Ezetimibe 10mg TabDIN 02416409 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| Ran-Ezetimibe 10mg TabDIN 02419548 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Ezetimibe 10mg TabDIN 02416778 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
| Teva-Ezetimibe 10mg TabDIN 02354101 | Limited Use, codes 380, 381 | $0.1811per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
24:00 CARDIOVASCULAR DRUGS.
24:06 Antilipemic Drugs.
24:06:24 PCSK9 Inhibitors.